Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Latest filing published 12 Aug 2026 for Mineralys Therapeutics, Inc., €30k. Read the official filing
Filing timeline
BuySaleDavid Malcom Rodman
Insider track record
Disclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
David Malcom Rodman: trading record in brief
This profile gathers the share dealings of David Malcom Rodman in Mineralys Therapeutics, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 10 August 2023 to 10 August 2026, the count stands at 63 filings.
Sales make up the whole of the open-market record (12 sales, €2.0M). Other entries cover 1 share grant and 50 option exercises. In 2026 alone, the filings show no purchases and 9 sales.
The latest filing, published on 12 August 2026, reports an open-market sale of €51k in Mineralys Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David Malcom Rodman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations63 total
2,170 shares@ US$16.000.0014% mcap0.8% of flowCommon StockSEC:0001933414-26-000118:0
2,170 shares@ US$27.090.0024% mcap1.4% of flowCommon StockSEC:0001933414-26-000118:1
416 shares@ US$26.530.0005% mcap0.3% of flowCommon StockSEC:0001672659-26-000036:1
416 shares@ US$15.440.0003% mcap0.2% of flowCommon StockSEC:0001672659-26-000036:0
14,058 shares@ US$27.57980.014% mcap9.2% of flowCommon StockSEC:0001933414-26-000099:3
6,349 shares@ US$26.61120.0059% mcap4.0% of flowCommon StockSEC:0001933414-26-000099:4
3,542 shares@ US$10.200.0013% mcap0.9% of flowCommon StockSEC:0001933414-26-000099:0
4,167 shares@ US$14.250.0021% mcap1.4% of flowCommon StockSEC:0001933414-26-000099:1
6,349 shares@ US$1.080.0002% mcap0.2% of flowCommon StockSEC:0001933414-26-000099:2
2,171 shares@ US$16.000.0014% mcap1.6% of flowCommon StockSEC:0001672659-26-000033:0
2,171 shares@ US$30.300.0028% mcap1.5% of flowCommon StockSEC:0001672659-26-000033:1
2,171 shares@ US$16.000.0013% mcap1.9% of flowCommon StockSEC:0001672659-26-000027:0
416 shares@ US$15.440.0002% mcap0.2% of flowCommon StockSEC:0001672659-26-000024:0
416 shares@ US$31.330.0005% mcap0.5% of flowCommon StockSEC:0001672659-26-000024:1
6,349 shares@ US$1.080.0003% mcap0.2% of flowCommon StockSEC:0001933414-26-000076:0
3,542 shares@ US$10.200.0014% mcap1.3% of flowCommon StockSEC:0001933414-26-000076:1
4,167 shares@ US$14.250.0022% mcap2.1% of flowCommon StockSEC:0001933414-26-000076:2
14,058 shares@ US$26.53910.014% mcap13.1% of flowCommon StockSEC:0001933414-26-000076:3
6,348 shares@ US$27.660.0066% mcap6.2% of flowCommon StockSEC:0001933414-26-000076:4
2,170 shares@ US$16.001.2% of flowCommon StockSEC:0001672659-26-000020:0
2,170 shares@ US$27.382.0% of flowCommon StockSEC:0001672659-26-000020:1
417 shares@ US$15.440.3% of flowCommon StockSEC:0001672659-26-000018:0
6,348 shares@ US$1.080.0003% mcap0.4% of flowCommon StockSEC:0001933414-26-000058:0
2,171 shares@ US$16.001.6% of flowCommon StockSEC:0001672659-26-000015:0
38,400 shares0Common StockSEC:0001933414-26-000038:0
25 of 63 declarations
